Compare Rent the Runway Inc (RENT) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Rent the Runway Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Rent the Runway Inc trades at $1.76 (market cap $61.75M), while State Street SPDR S&P Biotech ETF trades at $153.81 (market cap $10.11B). The key difference: State Street SPDR S&P Biotech ETF is far larger — about 163.7× Rent the Runway Inc's market cap, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Rent the Runway Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Rent the Runway Inc for 56 Days and State Street SPDR S&P Biotech ETF for 38 Days on average.
| RENT | XBI | |
|---|---|---|
Market Cap | $61.75M | $10.11B |
Volume | 193,323 | 12,903,266 |
Sector | Consumer Cyclical | Broad Market / Factor |
52-Week High | $9.39 | $169.55 |
52-Week Low | $1.55 | $104.99 |
Typical Hold Time | 56 Days | 38 Days |
Enterprise Value | $228.75M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Rent the Runway (RENT) trades at $1.77, up 5.36% today, with a bullish technical signal despite mixed indicators. The company reported Q2 2026 revenue growth of 20.8% year-over-year to $97.7 million, with improved gross margins, and appointed Paige Thomas as CEO in September 2026. However, it faces negative shareholder equity of -$182.5 million and a high debt-to-asset ratio of 139.62% as of 2025, though net losses have narrowed from -$212 million in 2022 to -$69.9 million in 2025.
The outlook is cautiously optimistic, with revenue growth and margin expansion offering potential upside, but significant financial leverage and ongoing legal investigations pose substantial risks. Analyst consensus is mixed, with 42% buy ratings, reflecting the balance between operational improvements and balance sheet concerns.
XBI trades at $153.84, up 2.4% today, but technical indicators signal a bearish trend with resistance at $154. The ETF's modified equal-weight structure offers broad biotech exposure, benefiting from M&A activity and positive clinical catalysts, though key financial ratios are unavailable. Recent news highlights sector optimism driven by cancer vaccine breakthroughs and improved capital access.
Outlook is mixed: bullish sentiment from innovation and M&A supports growth potential, but high volatility and expense ratios relative to peers pose risks. Analyst consensus is neutral (100% Hold), suggesting cautious optimism amid technical bearishness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Rent the Runway Inc
Rent the Runway Inc is an e-commerce platform that allows users to rent, subscribe, or buy designer apparel and accessories.
Read more on RENT →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
